GlassScriptPhysician profile
Sini Mathew
NPI 1922642453
$3,047.95
in general payments reported to CMS, 2019-2025
21 companies · $983 in 2025
The $983 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $802 · 2022: $255 · 2023: $233 · 2024: $775 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $537.78 | 2023-2025 | Epclusa, Livdelzi, Vemlidy |
| Amgen INC. | $371.97 | 2024-2025 | Repatha |
| Novo Nordisk INC | $299.63 | 2021 | |
| Genzyme Corporation | $234.40 | 2021-2024 | |
| Corcept Therapeutics | $206.12 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $161.21 | 2021-2022 | |
| Abiomed | $125.69 | 2025 | |
| Abbvie INC. | $124.98 | 2024 | |
| Alexion Pharmaceuticals, INC. | $121.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $120.14 | 2021 | |
| Inspire Medical Systems, INC. | $118.62 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $117.61 | 2024 | Wainua |
| Vertex Pharmaceuticals Incorporated | $96.19 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $95.32 | 2022 | |
| Eisai INC. | $84.38 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $60.65 | 2022 | |
| Coloplast Corp | $57.11 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.19 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $31.30 | 2021 | |
| Dexcom, INC. | $20.28 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sini Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.